<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of a hospitalized child or adolescent with acute severe ulcerative colitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of a hospitalized child or adolescent with acute severe ulcerative colitis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of a hospitalized child or adolescent with acute severe ulcerative colitis</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm summarizes the authors' approach to a child with acute severe ulcerative colitis without toxic megacolon or other indications for emergency colectomy. For details, refer to UpToDate content on management of the hospitalized child with acute severe ulcerative colitis.</div><div class="graphic_footnotes"><p>anti-TNF: anti-tumor necrosis factor; IV: intravenous; JAK: Janus kinase.</p>
<p>* Supportive care consists of hydration; nutrition; and management of pain, anemia, or hypoalbuminemia, as needed.</p>
<p>¶ Children who respond well to an initial course of IV glucocorticoids are typically weaned to oral glucocorticoids while adding a maintenance agent. For details, refer to UpToDate content on management of mild to moderate ulcerative colitis in children.</p>
Δ Counseling for patients/families on medical rescue therapy versus colectomy:
<ul>
<li>Surgery:
    <ul>
<li>Improves symptoms most quickly because it removes the diseased colon.</li>
<li>After surgery, most patients will have an ileostomy for at least 3 months and can subsequently choose to proceed to a J-pouch.</li>
<li>After J-pouch surgery, most patients have bowel movements several times a day.</li>
<li>After surgery, some people have problems with inflammation in the pouch or incontinence, which can be treated. Some women may have reduced fertility.</li>
<li>Surgery eliminates the long-term risk for colon cancer and the need for frequent colonoscopies to monitor for colon cancer.</li>
</ul>
</li>
<li>Medical rescue therapy:
    <ul>
<li>Approximately 75% respond at least temporarily, but approximately one-half of these people will lose response by 1 year. They will need to move on to colectomy or to one of the second-line options below.</li>
<li>These drugs suppress the immune system and require monitoring for safety.</li>
<li>These drugs are expensive. They are usually covered by medical insurance.</li>
</ul>
</li>
<li>Second-line medical options:
    <ul>
<li>These medications sometimes work (tofacitinib, upadacitinib), but we don't really know how often.</li>
<li>Most of the information about effectiveness and risks of these therapies is from studies in nonhospitalized adults with ulcerative colitis.</li>
<li>Insurance does not always pay for these drugs.</li>
</ul>
</li>
</ul>
<p class="extra_spacing">◊ The majority of centers in the United States utilize infliximab as first-line rescue therapy in acute severe colitis due to ease of use. However, evidence suggests that calcineurin inhibitors have comparable efficacy<sup>[1]</sup> and there is extensive experience with calcineurin inhibitors in both pediatric and adult centers.</p>
§ Limited data exist in support of JAK inhibitors (tofacitinib, upadacitinib) in acute severe colitis. These are off-label uses in pediatric patients. The choice depends on clinician experience with the agent and considerations of their toxicities, based on indirect evidence from adult studies in acute severe colitis<sup>[2]</sup>. Another option for this stage is changing from infliximab to a calcineurin inhibitor and vice versa. Sequential use of immunosuppressive agents may increase the risk of infection, but overall risks are generally acceptable, based primarily on indirect evidence from adults with inflammatory bowel disease or children with autoimmune diseases.</div><div class="graphic_reference">References:
<ol>
<li>Zimmerman LA, Spaan J, Weinbren N, et al. Efficacy and safety of tacrolimus or infliximab therapy in children and young adults with acute severe colitis. J Pediatr Gastroenterol Nutr 2023; 77:222.</li>
<li>Berinstein JA, Sheehan JL, Dias M, et al. Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: A retrospective case-control study. Clin Gastroenterol Hepatol 2021; 19:2112.</li>
</ol></div><div id="graphicVersion">Graphic 142632 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
